Ossiam Decreases Stock Holdings in MetLife, Inc. (NYSE:MET)

Ossiam cut its stake in MetLife, Inc. (NYSE:METFree Report) by 12.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,942 shares of the financial services provider’s stock after selling 4,287 shares during the period. Ossiam’s holdings in MetLife were worth $2,046,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC increased its holdings in shares of MetLife by 678.4% during the 4th quarter. International Assets Investment Management LLC now owns 287,311 shares of the financial services provider’s stock worth $19,000,000 after buying an additional 250,402 shares during the last quarter. AustralianSuper Pty Ltd raised its position in MetLife by 19.2% in the fourth quarter. AustralianSuper Pty Ltd now owns 1,824,596 shares of the financial services provider’s stock valued at $120,661,000 after purchasing an additional 293,925 shares during the period. Nordea Investment Management AB lifted its stake in shares of MetLife by 9.9% in the 4th quarter. Nordea Investment Management AB now owns 2,664,012 shares of the financial services provider’s stock valued at $176,304,000 after purchasing an additional 240,564 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH grew its holdings in shares of MetLife by 13.1% during the 4th quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 742,302 shares of the financial services provider’s stock worth $49,088,000 after purchasing an additional 86,091 shares during the period. Finally, Stifel Financial Corp increased its position in shares of MetLife by 1.8% during the 4th quarter. Stifel Financial Corp now owns 2,005,738 shares of the financial services provider’s stock worth $132,641,000 after purchasing an additional 35,782 shares during the last quarter. Hedge funds and other institutional investors own 89.81% of the company’s stock.

Insider Transactions at MetLife

In related news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the sale, the insider now owns 146,981 shares in the company, valued at $10,567,933.90. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares in the company, valued at approximately $4,174,893.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the sale, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The disclosure for this sale can be found here. Insiders own 0.31% of the company’s stock.

MetLife Stock Up 0.0 %

MET stock opened at $70.05 on Monday. The company’s 50 day moving average price is $71.76 and its 200 day moving average price is $69.50. The firm has a market capitalization of $49.81 billion, a price-to-earnings ratio of 24.07, a PEG ratio of 0.59 and a beta of 1.12. MetLife, Inc. has a fifty-two week low of $52.97 and a fifty-two week high of $74.68. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.83 EPS for the quarter, meeting analysts’ consensus estimates of $1.83. The company had revenue of $17.02 billion for the quarter, compared to the consensus estimate of $17.73 billion. MetLife had a net margin of 3.50% and a return on equity of 20.39%. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.52 EPS. On average, equities research analysts anticipate that MetLife, Inc. will post 8.62 EPS for the current fiscal year.

MetLife announced that its Board of Directors has authorized a share buyback program on Wednesday, May 1st that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to reacquire up to 6% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

MetLife Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 11th. Shareholders of record on Tuesday, May 7th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 3.11%. This is an increase from MetLife’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, May 6th. MetLife’s payout ratio is 74.91%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on MET. Keefe, Bruyette & Woods lowered their target price on shares of MetLife from $87.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 7th. Piper Sandler lowered their price objective on shares of MetLife from $85.00 to $82.00 and set an “overweight” rating for the company in a research report on Monday, May 6th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research report on Saturday, May 11th. Morgan Stanley raised their price target on MetLife from $80.00 to $82.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. Finally, Wells Fargo & Company cut their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a report on Friday, May 10th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $79.08.

Read Our Latest Analysis on MET

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.